About Omico
Omico is changing the way we fight cancer by accelerating access to precision oncology trials. We are a national, independent, not-for-profit organisation, uniting Australia’s world-class cancer institutes, researchers, clinicians, industry partners and government like never before. By leveraging a nationwide network of expertise and resources, we are facilitating the delivery of genomic cancer medicine clinical trials to thousands of Australians with advanced and incurable cancers. With fast-tracked molecular and genomic screening, biomarker-led trial set up and patient enrolment from the entire nation, we’re accelerating access to next generation treatments and preventive strategies.
Our Network & Partners
Omico brings together a nationwide network of government, healthcare, research, industry and patient advocacy partners to advance precision oncology in Australia. Through these collaborations, we help expand access to molecular screening, clinical trials and research, supporting better outcomes for Australians affected by cancer. Outsmarting cancer, together.
Our Board
Omico’s Board brings together expertise across cancer research, healthcare, industry, governance and strategy to guide our work and support our national role in advancing precision oncology in Australia.
Our Leadership Team
Omico’s Leadership Team brings together diverse expertise to lead our national programs and advance precision oncology in Australia.
Our Molecular Oncology Board
Expertise guiding clinicians and patients to targeted treatments.
Our Programs
Using genomics to identify therapeutic options for patients with advanced or incurable cancer and personalise cancer risk.
Events and Resources
Explore educational events and resources for people with professional or personal interests in cancer care, including scientific presentations, webinars and podcasts.
Publications
Research and evidence generation are central to Omico’s mission to improve outcomes through precision oncology.
Annual Reports
Explore Omico’s Annual Reports to learn more about our strategy, achievements, partnerships and impact in expanding access to precision oncology, advancing research and improving outcomes for Australians affected by cancer.